MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese

Fu-Chih Hsiao; Yung-Hsin Yeh; Wei-Jan Chen; Yi-Hsin Chan; Chi-Tai Kuo; Chun-Li Wang; Chi-Jen Chang; Hsin-Yi Tsai; Feng-Chun Tsai; Lung-An Hsu
April 2016
International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p521
Academic Journal
Matrix metalloproteinase (MMP) plays an important role in the pathogenesis of atrial fibrillation (AF). The MMP9 promoter has a functional polymorphism rs3918242 that can regulate the level of gene transcription. This study recruited 200 AF patients and 240 controls. The MMP9 rs3918242 was examined by polymerase chain reactions. HL-1 atrial myocytes were cultured and electrically stimulated. Right atrial appendages were obtained from six patients with AF and three controls with sinus rhythm undergoing open heart surgery. The MMP9 expression and activity were determined using immunohistochemical analysis and gelatin zymography, respectively. Rapid pacing induces MMP9 secretion from HL-1 myocytes in a time- and dose-dependent manner. The responsiveness of MMP9 transcriptional activity to tachypacing was significantly enhanced by rs3918242. The expression of MMP9 was increased in fibrillating atrial tissue than in sinus rhythm. However, the distribution of rs3918242 genotypes and allele frequencies did not significantly differ between the control and AF groups. HL-1 myocyte may secrete MMP9 in response to rapid pacing, and the secretion could be modulated by rs3918242. Although the MMP9 expression of human atrial myocyte is associated with AF, our study did not support the association of susceptibility to AF among Taiwanese subjects with the MMP9 rs3918242 polymorphism.


Related Articles

  • KCNE1 rs1805127 Polymorphism Increases the Risk of Atrial Fibrillation: A Meta-Analysis of 10 Studies. Liang, Chang; Li, Xiankai; Xu, Yawei; Chen, Qingyong; Wu, Yadong; Wang, Wan; Li, Weiming; Qiu, Mantang // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: Atrial fibrillation (AF) is one of the most common types of arrhythmia in humans. Recently, many studies have investigated the relationship between human atrial fibrillation and the single nucleotide polymorphism (SNP) of rs1805127 (A>G) in KCNE1 gene, but the results were still...

  • Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter and the Risk of Atrial Fibrillation in Taiwanese. Hsu, Lung-An; Yeh, Yung-Hsin; Kuo, Chi-Tai; Chen, Ying-Hwa; Chang, Gwo-Jyh; Tsai, Feng-Chun; Chen, Wei-Jan // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Atrial fibrillation (AF) is associated with increased oxidative stress. Emerging evidence suggests that heme oxygenase-1 (HO-1) is a potent antioxidant system against various oxidative stress-related diseases. The human HO-1 promoter has a GT-repeat length polymorphism that can...

  • CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control Study. Galati, Francesca; Colonna, Paolo; Galati, Antonio; Ciardiello, Carmine; Bozzetti, Maria P.; Massari, Serafina // JAFIB: Journal of Atrial Fibrillation;Apr/May2014, Vol. 6 Issue 6, p24 

    The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from high-density lipoproteins (HDL) to triglyceride (TG)-rich lipoproteins. A consistent number of investigations has suggested an association between the TaqIB polymorphism of the CETP gene, plasma HDL-C...

  • Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based study. Smith, J. Gustav; Melander, Olle; Sjögren, Marketa; Hedblad, Bo; Engström, Gunnar; Newton-Cheh, Christopher; Platonov, Pyotr G. // European Journal of Heart Failure;Mar2013, Vol. 15 Issue 3, p250 

    Aims Atrial fibrillation (AF) is a frequent co-morbidity in heart failure (HF) associated with increased mortality, but little is known about the mechanisms underlying AF onset in HF patients. We evaluated the association of cardiovascular and genetic risk factors with AF in HF patients. Methods...

  • Dabigatran vs warfarin: Less bleeding?  // Internal Medicine Alert;11/17/2009 Supplement, p21 

    The article reports on the results of a study regarding the effective use of dabigatran (DAB) and warfarin (WRF) in the reduction of atrial fibrilation (AF) risk factors.

  • Atrial fibrillation increases risk of stroke mortality.  // Geriatrics;May97, Vol. 52 Issue 5, p100 

    Presents an abstract of the article `Atrial Fibrillation and Stroke: Mortality and Causes of Death After the First Acute Ischemic Stroke,' by MM Kaarisalo, P. Immonen-Raiha, et al from the `Stroke' dated February 1997.

  • QUICK STUDIES. Hearts Aflutter.  // Nutrition Action Health Letter;Sep2010, Vol. 37 Issue 7, p9 

    The article discusses research being done on the prevalence of atrial fibrillation among obese people which references studies published in the 2010 issues of the "Journal of the American College Cardiology" and the "American Journal of Clinical Nutrition."

  • Erratum to: Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis. Rhee, C. W.; Lee, J.; Oh, S.; Choi, N. K.; Park, B. J. // Osteoporosis International;Jan2012, Vol. 23 Issue 1, p255 

    A correction is presented to the article "Use of biphosphonate and risk of atrial fibrillation in older women with osteoporosis," by C. W. Rhee, J. Lee, S. Oh et al. originally published in a previous issue of the journal.

  • Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study. Huxley, Rachel R.; Lopez, Faye L.; MacLehose, Richard F.; Eckfeldt, John H.; Couper, David; Leiendecker-Foster, Catherine; Hoogeveen, Ron C.; Chen, Lin Yee; Soliman, Elsayed Z.; Agarwal, Sunil K.; Alonso, Alvaro // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Background: Previous cross-sectional studies have suggested that biomarkers of extracellular matrix remodelling are associated with atrial fibrillation (AF), but no prospective data have yet been published. Hence, we examine whether plasma matrix metalloproteinases (MMP) and their inhibitors...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics